Watch BMEA. Know when insiders buy.
One email the day a filing lands. Free.
BMEA
Biomea Fusion, Inc.
1.93
−0.10 −4.93%
USD · close Sep 8
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
55
WATCH · shorts 55
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $139.9MP/E —DIV YIELD —FCF YIELD —REV TTM —NET INCOME −$32.5MNET CASH —52W 0.96 – 2.67SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | — | — | — | −$12.8M | −$8.3M | — | -0.12 | −$10M | — | — | Aug 5 |
| Q1 2026 · Mar 31 | — | — | — | −$12.8M | −$12.4M | — | -0.17 | −$11.7M | — | — | Aug 5 |
| Q4 2025 · Dec 31derived | — | — | — | −$11.7M | $4.6M | — | 0.27 | −$13.9M | — | — | Mar 24 |
| Q3 2025 · Sep 30 | — | — | — | −$20.8M | −$16.4M | — | -0.27 | −$11.6M | $0 | −$11.6M | Nov 4 |
| Q2 2025 · Jun 30 | — | — | — | −$21.3M | −$20.7M | — | -0.51 | −$19.2M | $0 | −$19.2M | Aug 5 |
| Q1 2025 · Mar 31 | — | — | — | −$29.7M | −$29.3M | — | -0.80 | −$25.7M | $0 | −$25.7M | Aug 5 |
| Q4 2024 · Dec 31 | — | — | — | −$30.1M | −$29.3M | — | -0.81 | −$30M | $82K | −$30.1M | Mar 24 |
| Q3 2024 · Sep 30 | — | — | — | −$34M | −$32.8M | — | -0.91 | −$25.2M | $186K | −$25.4M | Nov 4 |
| Q2 2024 · Jun 30 | — | — | — | −$38.9M | −$37.3M | — | -1.03 | −$32.6M | $59K | −$32.7M | Nov 4 |
| Q1 2024 · Mar 31 | — | — | — | −$41.1M | −$39.1M | — | -1.09 | −$32M | $35K | −$32.1M | Nov 4 |
| Q4 2023 · Dec 31 | — | — | — | −$37.3M | −$34.9M | — | -0.98 | −$22.8M | $8K | −$22.8M | Mar 24 |
| Q3 2023 · Sep 30 | — | — | — | −$31.1M | −$28.4M | — | -0.80 | −$23.9M | $39K | −$23.9M | Mar 31 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | — | — | −$83.5M | −$61.8M | — | -1.18 | −$70.4M | — | — | — | — |
| FY2024 · to Dec 31 | — | — | −$144.1M | −$138.4M | — | -3.83 | −$119.9M | $362K | −$120.3M | — | — |
| FY2023 · to Dec 31 | — | — | −$126.1M | −$117.3M | — | -3.44 | −$96.6M | $3.4M | −$100M | — | — |
| FY2022 · to Dec 31 | — | — | −$83.6M | −$81.8M | — | -2.80 | −$62.4M | $1M | −$63.4M | — | — |
| FY2021 · to Dec 31 | — | — | −$41.7M | −$41.6M | — | -1.74 | −$35.4M | $3.2M | −$38.6M | — | — |
| FY2020 · to Dec 31 | — | — | −$5.3M | −$5.3M | — | -0.51 | −$4.5M | $51K | −$4.5M | — | — |
Every number comes from Biomea Fusion, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.